S&P 500

5.705,45

-1,86%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Praecis Pharmaceuticals (MM) (PRCS)
Praecis Pharmaceuticals (MM) (PRCS) Notícias

PRCS

Praecis (PRCS)

Praecis Pharmaceuticals (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PRCS

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
16/02/2007	11:30	PR Newswire (US)	GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
15/02/2007	12:00	PR Newswire (US)	GlaxoSmithKline Extends Subsequent Offering Period By One Day	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
07/02/2007	12:11	PR Newswire (US)	GlaxoSmithKline Accepts Shares in Tender Offer for Shares of PRAECIS PHARMACEUTICALS and Commences Subsequent Offering Period	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
09/01/2007	12:03	PR Newswire (US)	GlaxoSmithKline Commences Tender Offer to Acquire PRAECIS PHARMACEUTICALS	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
09/11/2006	10:15	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2006 Financial Results	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
08/11/2006	10:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Presents Interim Clinical Data on PPI-2458 at the 18th EORTC-NCI-AACR Symposium	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
01/11/2006	16:02	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter Financial Results on Thursday, November 9, 2006	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
24/10/2006	08:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Receives the Cerep Award for Research Related to Its Investigational Drug Candidate, PPI-24	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
18/10/2006	08:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
04/08/2006	08:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Reports Second Quarter 2006 Financial Results	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
01/08/2006	17:30	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED to Announce Second Quarter Financial Results on Friday, August 4, 2006	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
20/06/2006	08:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Announces Cessation of Plenaxis(R) Disposition Efforts; Plans to Explore Financing Alterna	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
05/05/2006	08:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Reports First Quarter 2006 Financial Results	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
28/04/2006	08:30	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED To Announce First Quarter Financial Results on Friday, May 5, 2006	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
20/04/2006	09:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Appoints Prem Das as Senior Vice President, Technology Partnerships	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
10/04/2006	08:30	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Announces Pilot Study and Option Agreement with GlaxoSmithKline to Utilize DirectSelect(TM	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
21/03/2006	09:30	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Announces Technology Transfer and Option Agreement with Gilead Sciences, Inc. to Utilize D	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
15/03/2006	10:30	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Presents Update on its DirectSelect(TM) Technology	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
09/03/2006	16:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458 in Rheumatoid Arthritis	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
03/02/2006	10:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Reports Fourth Quarter and Year End 2005 Financial Results	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
30/01/2006	17:40	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED To Announce Fourth Quarter and Year End 2005 Financial Results on Friday, February 3, 2006	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
07/11/2005	21:15	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED To Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on November 9,	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
04/11/2005	10:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2005 Financial Results	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
01/11/2005	10:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter 2005 Financial Results on Friday, November 4, 2005	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
27/10/2005	18:17	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Stockholders Authorize Reverse Stock Split; Board Sets 1-for-5 Split Ratio	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
19/10/2005	09:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Completes Sale of Facility for $51.25 Million	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
11/10/2005	10:12	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Announces Agreement for Sale of Facility	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
28/09/2005	21:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Announces German Regulatory Approval for Plenaxis(R); Schering AG Collaboration Terminated	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
05/08/2005	08:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Reports Second Quarter 2005 Financial Results	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)
06/05/2005	08:00	Business Wire	PRAECIS PHARMACEUTICALS INCORPORATED Reports First Quarter 2005 Financial Results	NASDAQ:PRCS	Praecis Pharmaceuticals (MM)